Mason Stands By Cholesterol, Migraine Claims Despite "Courtesy" Letter
This article was originally published in The Tan Sheet
Executive Summary
Eight supplement makers received FDA "courtesy" letters recently regarding their structure/function claims for cholesterol reduction, the latest in a string of such letters targeting cholesterol claims. One of the firms, Mason Vitamins, is standing by its claims in spite of the March 23 advisory letter from FDA saying they are unapproved drug claims.